KIDINS 220 GENOMA ESPAÑA XXI SL
Company details
- Active NIF/CIF: B20798419
-
-
-
-
Address: San Martzial Kalea, 32, 20005 Donostia, Gipuzkoa, España See in map
-
-
Featured products:
More information on KIDINS 220 GENOMA ESPAÑA XXI SL
-
10/10/2007 | BORME act no.: 801368 | Register: GUIPÚZCOADepósito de cuentas anuales (Septiembre de 2007)
-
13/04/2007 | BORME act no.: 158489 | Register: GUIPÚZCOADepósito de cuentas anuales (Marzo de 2007)
-
21/04/2005 | BORME act no.: 103723 | Register: GUIPÚZCOADepósito de cuentas anuales (Marzo de 2005)
-
24/02/2005 | BORME act no.: 86357 | Register: GUIPÚZCOACierre provisional hoja registral art 1372 Ley 43/1995 Impuesto de Sociedades
-
07/03/2003 | BORME act no.: 98567 | Register: GUIPÚZCOAConstitución
-
07/03/2003 | BORME act no.: 98567 | Register: GUIPÚZCOANombramientos
Other information
The CIF of KIDINS 220 GENOMA ESPAÑA XXI SL is B20798419 and its business status is active. Its economic activity belongs to the CNAE 7219 - Otra investigación y desarrollo experimental en ciencias naturales y técnicas. Its SIC is 8731 - Investigación física comercial.
KIDINS 220 GENOMA ESPAÑA XXI SL has Between 10 and 49 employees employees and an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Guipúzcoa. It has a total of 1 registration charges. Its last announcement in Borme was published on 10/10/2007 and the latest ordinary annual accounts are from the year -.
You can review the contact information of KIDINS 220 GENOMA ESPAÑA XXI SL such as the phone number, address, or website in the Company Data module.
For more information about KIDINS 220 GENOMA ESPAÑA XXI SL, you can consult any of our available financial reports, the Annual Accounts of the company, or even check its payment incidents in the RAI delinquency file.
All the financial, commercial, and legal information we provide about the company name comes from official sources and is updated daily.
Do you want to know more about KIDINS 220 GENOMA ESPAÑA XXI SL??
Find out more about this company by consulting these reports: